Predictive Health Intelligence

Predictive Health Intelligence is a UK-based health technology company specializing in the early identification of chronic liver disease through advanced data analytics. The company's flagship platform, Hebe, utilizes existing longitudinal blood test data from primary and secondary care to identify patients at high risk of cirrhosis and advanced fibrosis who have been missed by standard clinical pathways. By automating the screening process without requiring new tests, the company enables earlier intervention and improved patient outcomes for conditions such as MASLD and NAFLD. Predictive Health Intelligence works closely with the NHS to integrate its diagnostic software into clinical workflows, aiming to reduce the burden of late-stage liver disease.